Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-11-23-Speech-2-937"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2010-11-23"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"pt"^^xsd:language2
lpv:document identification number	"en.20101123.33.2-937"2
lpv:hasSubsequent	lp_eu:2010-11-23-Speech-2-9362
lpv:speaker	lp:José Manuel Fernandes2
lpv:spokenAs	substitute; Delegation to the ACP-EU Joint Parliamentary Assembly (2010-03-05--2014-06-30)3 member; BUDG (2009-07-16--2012-01-18)3 substitute; Delegation for relations with India (2009-09-16--2014-06-30)3 member; Delegation for relations with the People's Republic of China (2009-09-16--2014-06-30)3 substitute; ENVI (2009-07-16--2012-01-18)3 member; Special committee on the policy challenges and budgetary resources for a sustainable European Union after 2013 (2010-06-17--2011-06-30)3 member; EPP (2009-07-14--2014-06-30)3 unknown; Partido Social Democrata (2009-07-14--2014-06-30)3
lpv:translated text	"This proposal invited the Council and Parliament to authorise the addition of a further 718 pharmaceutical and chemical products to the existing list of 8 619 products benefiting from bound duty-free treatment upon importation into the EU. This issue is not controversial, as there is consensus among the stakeholders, and it has the support of the Member States. Lists are put together by the industry and decided on by consensus by the participants. This addition of products is necessary to respond to the rapidly changing product environment in the pharmaceutical industry. The intended date of implementation is 1 January 2011. The US has made the implementation of the update conditional upon implementation on 1 January. Other participants are expected to follow this example, except Japan, which has announced an expected delay of 6 months in implementation."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph